Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective

Chemists have been fascinated for a long time with phenomenon of bimolecular spectroscopy and dynamics of Nano–sized molecules and clusters as cross–linking–induced anti–cancer and Immune-Oncology (I-O) Nano drugs delivery in DNA/RNA of human cancer cells’ membranes under synchrotron radiations [1–25]. This concept generally associated with anti– cancer and Immune-Oncology (I-O) Nano drugs delivery under synchrotron radiations, now extends equally well to synchrotron chemistry. Despite its continuing very frequent use in the scientific literature, anti–cancer and Immune-Oncology (I-O) Nano drugs delivery under synchrotron radiations like many other useful and popular chemical concepts is non–reductive and lacks an unambiguous basis. It has no precise quantitative definition and is not directly measureable experimentally. In other words, anti–cancer and Immune-Oncology (I-O) Nano drugs delivery under synchrotron radiations is a virtual quantity, rather than a physical observable. Since anti–cancer and Immune-Oncology (I-O) Nano drugs delivery under synchrotron radiations is not a directly measureable quantity, its magnitude is now generally evaluated in terms of structural, energetic and magnetic criteria. However, magnetic properties are the most closely related to anti–cancer and Immune-Oncology (I-O) Nano drugs delivery under synchrotron radiations, as they depend directly on the induced ring currents associated with cyclic electron delocalization. The main purpose of this editorial is to show how the different criteria can be used to describe the Nano drugs delivery under synchrotron radiations of various Nano–sized molecules and clusters as cross–linking–induced anti–cancer and Immune-Oncology (I-O) Nano drugs in DNA/RNA of human cancer cells’ membranes.